| Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity BDG Page, H Khoury, RC Laister, S Fletcher, M Vellozo, A Manzoli, P Yue, ... Journal of medicinal chemistry 55 (3), 1047-1055, 2012 | 120 | 2012 |
| An upstream insulator regulates DLK1 imprinting in AML H Khoury, F Suarez-Saiz, S Wu, MD Minden Blood 115 (11), 2260-2263, 2010 | 57 | 2010 |
| Acute myelogenous leukemia with t (8; 21)—identification of a specific immunophenotype H Khoury, BI Dalal, TJ Nevill, DE Horsman, MJ Barnett, JD Shepherd, ... Leukemia & lymphoma 44 (10), 1713-1718, 2003 | 56 | 2003 |
| Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia YS Meng, H Khoury, JE Dick, MD Minden Leukemia 19 (11), 1941-1947, 2005 | 52 | 2005 |
| Multicolor karyotyping and clinicopathological analysis of three intravascular lymphoma cases H Khoury, VS Lestou, RD Gascoyne, H Bruyere, CH Li, SH Nantel, ... Modern pathology 16 (7), 716-724, 2003 | 46 | 2003 |
| The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells Y Han, S San-Marina, L Yang, H Khoury, MD Minden Breast cancer research 9, 1-13, 2007 | 24 | 2007 |
| Correlation between karyotype and quantitative immunophenotype in acute myelogenous leukemia with t (8; 21) H Khoury, BI Dalal, SH Nantel, DE Horsman, JC Lavoie, JD Shepherd, ... Modern pathology 17 (10), 1211-1216, 2004 | 23 | 2004 |
| Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia C Hurtz, LN Chan, H Geng, E Ballabio, G Xiao, G Deb, H Khoury, ... Genes & development 33 (17-18), 1265-1279, 2019 | 21 | 2019 |
| Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or … G Dranitsaris, H Khoury Supportive Care in Cancer 19, 1807-1813, 2011 | 19 | 2011 |
| Aberrant expression of angiotensin in acute myeloid leukemia. RP Pinto, KK Wang, H Khoury, AD Schimmer, MD Minden Blood 102 (11), 577A-577A, 2003 | 13 | 2003 |
| Intravascular lymphoma presenting with bone marrow involvement and leukemic phase H Khoury, BI Dalal, SH Nantel Leukemia & lymphoma 44 (6), 1043-1047, 2003 | 12 | 2003 |
| Disseminated fusariosis in a patient with acute leukaemia H Khoury, NJ Ball British journal of haematology 120 (1), 1-1, 2003 | 11 | 2003 |
| Acute myelogenous leukemia complicated by acute necrotizing ulcerative gingivitis due to aspergillus terreus H Khoury, CF Poh, M Williams, JC Lavoie, TJ Nevill Leukemia & lymphoma 44 (4), 709-713, 2003 | 7 | 2003 |
| Octadecyloxyethyl Adefovir Exhibits Potent in vitro and in vivo Cytotoxic Activity and Has Synergistic Effects with Ara-C in Acute Myeloid Leukemia H Khoury, R He, A Schimmer, JR Beadle, KY Hostetler, MD Minden Chemotherapy 63 (4), 225-237, 2018 | 3 | 2018 |
| The role of gene translocations in the molecular pathogenesis of acute myeloid leukemia H Khoury Genetic Translocations and Other Chromosome Aberrations. Nova Science …, 2008 | 3 | 2008 |
| Quantitative immunophenotype (QUIP) pattern of CD34 (high), CD13 (high) and CD33 (low) identifies patients with acute myelogenous leukemia (AML) with inv (16). H Khoury, BI Dalal, TJ Nevill, DE Horsman, JD Shepherd, DE Hogge, ... Blood 98 (11), 109A-109A, 2001 | 3 | 2001 |
| Differential expression of the BCR gene in sequential stages of murine hematopoietic hierarchy H Khoury, M Barbara, NN Iscove, MD Minden Leukemia 25 (4), 711-713, 2011 | 1 | 2011 |
| Leukemias P Disperati, FJ Suarez‐Saiz, H Khoury, MD Minden TNM Online, 2003 | 1 | 2003 |
| Rationale for Targeting BCL6 in MLL-Rearranged B-ALL LN Chan, C Hurtz, H Geng, E Ballabio, G Xiao, G Deb, H Khoury, ... Blood 134, 1239, 2019 | | 2019 |
| Inhibition of WHSC1 As a Promising Therapeutic Strategy in Childhood ALL H Khoury, N Raynal, P St-Onge, M Caron, A Beaudry, D Sinnett Blood 130, 2072, 2017 | | 2017 |
